vs
Side-by-side financial comparison of Churchill Downs Inc (CHDN) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($761.7M vs $663.0M, roughly 1.1× Churchill Downs Inc). Churchill Downs Inc runs the higher net margin — 12.5% vs 12.0%, a 0.6% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 3.1%). Over the past eight quarters, Insulet Corporation's revenue compounded faster (24.9% CAGR vs -13.7%).
Churchill Downs Incorporated is the parent company of Churchill Downs. The company has evolved from one racetrack in Louisville, Kentucky, to a multi American-state-wide, publicly traded company with racetracks, casinos and an online wagering company among its portfolio of businesses.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
CHDN vs PODD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $663.0M | $761.7M |
| Net Profit | $83.0M | $91.1M |
| Gross Margin | — | 69.5% |
| Operating Margin | 21.6% | 16.0% |
| Net Margin | 12.5% | 12.0% |
| Revenue YoY | 3.1% | 33.9% |
| Net Profit YoY | 7.8% | 157.3% |
| EPS (diluted) | $1.16 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $663.0M | $761.7M | ||
| Q4 25 | $665.9M | $783.7M | ||
| Q3 25 | $683.0M | $706.3M | ||
| Q2 25 | $934.4M | $649.1M | ||
| Q1 25 | $642.6M | $569.0M | ||
| Q4 24 | $624.2M | $597.5M | ||
| Q3 24 | $628.5M | $543.9M | ||
| Q2 24 | $890.7M | $488.5M |
| Q1 26 | $83.0M | $91.1M | ||
| Q4 25 | $51.3M | $101.6M | ||
| Q3 25 | $38.1M | $87.6M | ||
| Q2 25 | $216.9M | $22.5M | ||
| Q1 25 | $76.7M | $35.4M | ||
| Q4 24 | $71.7M | $100.7M | ||
| Q3 24 | $65.4M | $77.5M | ||
| Q2 24 | $209.3M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | — | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | — | 67.7% |
| Q1 26 | 21.6% | 16.0% | ||
| Q4 25 | 18.5% | 18.7% | ||
| Q3 25 | 14.3% | 16.7% | ||
| Q2 25 | 35.1% | 18.7% | ||
| Q1 25 | 20.9% | 15.6% | ||
| Q4 24 | 20.3% | 18.3% | ||
| Q3 24 | 20.0% | 16.2% | ||
| Q2 24 | 37.0% | 11.2% |
| Q1 26 | 12.5% | 12.0% | ||
| Q4 25 | 7.7% | 13.0% | ||
| Q3 25 | 5.6% | 12.4% | ||
| Q2 25 | 23.2% | 3.5% | ||
| Q1 25 | 11.9% | 6.2% | ||
| Q4 24 | 11.5% | 16.9% | ||
| Q3 24 | 10.4% | 14.2% | ||
| Q2 24 | 23.5% | 38.6% |
| Q1 26 | $1.16 | $1.30 | ||
| Q4 25 | — | $1.42 | ||
| Q3 25 | — | $1.24 | ||
| Q2 25 | — | $0.32 | ||
| Q1 25 | — | $0.50 | ||
| Q4 24 | — | $1.38 | ||
| Q3 24 | — | $1.08 | ||
| Q2 24 | — | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $200.0M | $480.4M |
| Total DebtLower is stronger | $840.0M | $18.6M |
| Stockholders' EquityBook value | — | $1.3B |
| Total Assets | $7.5B | $3.0B |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $200.0M | $480.4M | ||
| Q4 25 | $200.6M | — | ||
| Q3 25 | $180.5M | — | ||
| Q2 25 | $182.4M | — | ||
| Q1 25 | $174.2M | — | ||
| Q4 24 | $175.5M | — | ||
| Q3 24 | $152.7M | — | ||
| Q2 24 | $140.3M | — |
| Q1 26 | $840.0M | $18.6M | ||
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.0B | $998.4M |
| Q1 26 | $7.5B | $3.0B | ||
| Q4 25 | $7.5B | $3.2B | ||
| Q3 25 | $7.5B | $3.0B | ||
| Q2 25 | $7.4B | $3.5B | ||
| Q1 25 | $7.3B | $3.5B | ||
| Q4 24 | $7.3B | $3.1B | ||
| Q3 24 | $7.2B | $3.0B | ||
| Q2 24 | $7.2B | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $295.0M | $113.8M |
| Free Cash FlowOCF − Capex | — | $89.5M |
| FCF MarginFCF / Revenue | — | 11.8% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | 3.55× | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.0M | $113.8M | ||
| Q4 25 | — | $183.3M | ||
| Q3 25 | $187.7M | $125.7M | ||
| Q2 25 | — | $196.5M | ||
| Q1 25 | $246.5M | $63.8M | ||
| Q4 24 | — | $147.7M | ||
| Q3 24 | $169.4M | $98.5M | ||
| Q2 24 | — | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | — | $48.2M | ||
| Q3 25 | $166.3M | $100.1M | ||
| Q2 25 | — | $177.9M | ||
| Q1 25 | $233.9M | $51.5M | ||
| Q4 24 | — | $94.1M | ||
| Q3 24 | $154.4M | $71.8M | ||
| Q2 24 | — | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | — | 6.2% | ||
| Q3 25 | 24.3% | 14.2% | ||
| Q2 25 | — | 27.4% | ||
| Q1 25 | 36.4% | 9.1% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | 24.6% | 13.2% | ||
| Q2 24 | — | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 2.6% | 17.2% | ||
| Q3 25 | 3.1% | 3.6% | ||
| Q2 25 | 2.0% | 2.9% | ||
| Q1 25 | 2.0% | 2.2% | ||
| Q4 24 | 5.4% | 9.0% | ||
| Q3 24 | 2.4% | 4.9% | ||
| Q2 24 | 2.5% | 4.6% |
| Q1 26 | 3.55× | 1.25× | ||
| Q4 25 | — | 1.80× | ||
| Q3 25 | 4.93× | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | 3.21× | 1.80× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | 2.59× | 1.27× | ||
| Q2 24 | — | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHDN
| Live and Historical Racing | $297.0M | 45% |
| Gaming | $257.0M | 39% |
| Wagering Services and Solutions | $109.0M | 16% |
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
